Gonadotropins are released in a pulsatile fashion at a frequency of between 1 and 2 hours
in the follicular phase of the menstrual cycle. Human menopausal gonadotropins are usually …

All IVF programs have a consistent rate of failure in inducing ovulations. Pharmacological
induction of ovulation is otherwise crucial for an IVF program because of the need for more …

Objectives To evaluate the effectiveness of and analyze the factors influencing the outcome
of three ovarian stimulation protocols used during in vitro fertilization (IVF) in a large …

The risk of developing gynaecological cancer following ovulation induction therapy in
infertile patients is not easy to determine due to many confounding factors. These include …

OBJECTIVE: To determine the effectiveness of human menopausal gonadotropin (hMG)
with intrauterine insemination (IUI) for the treatment of various causes of infertility and to …

Twenty-four couples with unexplained infertility were studied in a spontaneous cycle
followed by a clomiphene citrate (CC) cycle (150 mg, days 5–9). All spontaneous cycles …

Infertility itself increases the incidence of ovarian carcinoma, while the potential additional
risk associated with the use of fertility drugs is still debated. In 1992, the cumulative analysis …

Prevention of ovarian hyperstimulation syndrome -ORCA Cardiff University | Prifysgol Caerdydd
ORCA Online Research @ Cardiff Cardiff University | Prifysgol Caerdydd Welsh Clear Cookie …

Several lines of investigation suggest a direct modulatory role for gonadotrophin-releasing
hormone (GnRH) on granulosa cell functions. Also, GnRH and its analogues (GnRHa) have …

Uncertainty continues as to whether treatments for ovulation induction are associated with
increased risk of cancer. The authors conducted a long-term population-based historical …